Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula A Matulonis

Showing results (71-80 of 215) with videos related to

Pageof 22
Sort By:
Clinical Chemistry|October 15, 2010
CA125 immune complexes in ovarian cancer patients with low CA125 concentrationsDaniel W Cramer, Dennis J O'Rourke, Allison F Vitonis, et al.
Oncoimmunology|March 28, 2017
Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expressionBrooke E Howitt, Kyle C Strickland, Lynette M Sholl, et al.
Gynecologic Oncology|June 2, 2009
Comparison of the quality of life of early and advanced stage ovarian cancer survivorsKristina L Mirabeau-Beale, Alice B Kornblith, Richard T Penson, et al.
Gynecologic Oncology|June 16, 2004
Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignanciesRichard T Penson, Michael V Seiden, Annekathryn Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancerStephen A Cannistra, Ursula A Matulonis, Richard T Penson, et al.
Integrative Cancer Therapies|May 21, 2010
Acupuncture as palliative therapy for physical symptoms and quality of life for advanced cancer patientsElizabeth Dean-Clower, Anne M Doherty-Gilman, Aparna Keshaviah, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2025
Ovarian Sex Cord Tumor With Annular Tubules (SCTAT) Harbor Recurrent Copy Number Alterations, Including Monosomy 22Andrew M Leader, Alexander Neil, Stephanie Siegmund, et al.
Gynecologic Oncology|July 2, 2024
Improving the palliative-procedure decision-making process for patients with peritoneal carcinomatosis: A secondary analysisJaclyn A Wall, Rachel A Pozzar, Andrea C Enzinger, et al.
Gynecologic Oncology|May 24, 2019
Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancerJoyce F Liu, Kathryn P Gray, Alexi A Wright, et al.
Gynecologic Oncology|November 2, 2005
A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancerMichael V Seiden, Alan N Gordon, Diane C Bodurka, et al.
Pageof 22

Showing results (71-80 of 215) with videos related to

Sort By:
Pageof 22
Clinical Chemistry|October 15, 2010
CA125 immune complexes in ovarian cancer patients with low CA125 concentrationsDaniel W Cramer, Dennis J O'Rourke, Allison F Vitonis, et al.
Oncoimmunology|March 28, 2017
Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expressionBrooke E Howitt, Kyle C Strickland, Lynette M Sholl, et al.
Gynecologic Oncology|June 2, 2009
Comparison of the quality of life of early and advanced stage ovarian cancer survivorsKristina L Mirabeau-Beale, Alice B Kornblith, Richard T Penson, et al.
Gynecologic Oncology|June 16, 2004
Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignanciesRichard T Penson, Michael V Seiden, Annekathryn Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancerStephen A Cannistra, Ursula A Matulonis, Richard T Penson, et al.
Integrative Cancer Therapies|May 21, 2010
Acupuncture as palliative therapy for physical symptoms and quality of life for advanced cancer patientsElizabeth Dean-Clower, Anne M Doherty-Gilman, Aparna Keshaviah, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2025
Ovarian Sex Cord Tumor With Annular Tubules (SCTAT) Harbor Recurrent Copy Number Alterations, Including Monosomy 22Andrew M Leader, Alexander Neil, Stephanie Siegmund, et al.
Gynecologic Oncology|July 2, 2024
Improving the palliative-procedure decision-making process for patients with peritoneal carcinomatosis: A secondary analysisJaclyn A Wall, Rachel A Pozzar, Andrea C Enzinger, et al.
Gynecologic Oncology|May 24, 2019
Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancerJoyce F Liu, Kathryn P Gray, Alexi A Wright, et al.
Gynecologic Oncology|November 2, 2005
A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancerMichael V Seiden, Alan N Gordon, Diane C Bodurka, et al.
Pageof 22